This site is intended for Healthcare Professionals only.

Sanofi enters into a dual partnership agreement with Alliance Healthcare and Phoenix

Date:

Share post:

The groundbreaking collaboration is expected to improve service levels and stock availability of key products to UK pharmacies.

Opella Healthcare, trading as Sanofi Consumer Healthcare, recently signed a dual partnership agreement with Alliance Healthcare and Phoenix Healthcare Distribution for the wholesale supply of its consumer healthcare products to community pharmacies throughout the United Kingdom.

The new dual pharmacy wholesale partnership model, which became effective on 1 February 2024, underscores Sanofi’s commitment to delivering exceptional customer service to its customers, the company said in a press release.

The groundbreaking collaboration is expected to enhance operational efficiency as part of the company’s go-to-market model, facilitating improved service levels and stock availability of key products, including Cialis® Together, Allevia®, Buscopan®, Dulcolax®, and Phenergan, to community pharmacies in the UK.

Nick Linton, head of UK country operations, Sanofi Consumer Healthcare, said that the company is committed to supporting the “self-care agenda” in the UK.

“Making healthcare as simple as it should be to bring health and wellbeing to all is a key priority for us in 2024 and beyond,” he commented.

Sanofi’s new wholesale model reflects its deep commitment to working as efficiently as possible in “close partnership with pharmacists” to shape a healthier future, he added.

An innovative global healthcare company, Sanofi maintains a widespread presence spanning 100 countries, providing potentially life-changing treatment options and potentially life-saving vaccine protection to millions of people globally.

 

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue March 2024

Related articles

Head lice cases on the rise across the UK, warns Superdrug

If lotions or sprays prove ineffective, consulting a pharmacist about alternative head lice treatments is recommended Parents are...

Gender identity services: GPhC publishes new resource for pharmacy professionals

The regulatory body sets out questions that pharmacy professionals should ask themselves when providing gender identity care  The General...

NHS patient safety initiative: 143 hospitals across England to roll out Martha’s Rule

This programme has the opportunity to truly transform “patient care and safety” NHS England has confirmed the initial sites...

Why You Shouldn’t Delay in Filing a Medical Malpractice Claim

When faced with the unfortunate situation of medical malpractice, it’s understandable that you may feel overwhelmed and uncertain...